On May 11, 2021 CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, reported the Company will host a conference call reviewing the first quarter highlights at 8:00 a.m. ET on Thursday, May 13th, 2021 (Press release, CASI Pharmaceuticals, MAY 11, 2021, https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-report-first-quarter-2021-financial-results-and-host-conference-call-may-13-2021-301288283.html [SID1234579727]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On the call, CASI’s Chairman & CEO will provide an update on the Company’s business and upcoming milestones. The conference call can be accessed by dialing (833) 420-0382 (U.S.), 8008700181 (China), 58086567 (Hong Kong) to listen to the live conference call. The conference ID number for the live call is 7478587.

This call will be recorded and available for replay by dialing (800) 585-8367 (U.S.) or (404) 537-3406 (international) and enter 7478587 to access the replay.